Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval - Poll - MDSpire

Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval

  • By

  • Ayalew Tefferi

  • Animesh Pardanani

  • March 18, 2024

  • 0 min

Share

Original Source(s)

Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval

  • by Ayalew Tefferi, Animesh Pardanani

  • March 18, 2024

Related Content

Effect of preoperative anemia on surgical outcomes in endonasal transsphenoidal surgery for pituitary adenoma: a matched-cohort study

Novel PTRH2::ALK Fusion in ALK-positive Histiocytosis Presenting as a Liver Abscess in an Infant: A Case Study

The Role of Hemoglobin and Anemia in Preventing Dementia—Revisiting a Well-Known Protein